Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

RCAS-myrAkt Citations (5)

Plasmid Article: Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.
Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE Cancer Cell. 2002 Feb . 1(1):53-62.
PubMed Journal

Articles Citing RCAS-myrAkt

Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers. Brinkhoff B, Ostroumov D, Heemcke J, Woller N, Gurlevik E, Manns MP, Longerich T, Zender L, Harty JT, Kubicka S, Kuhnel F, Wirth TC. Eur J Immunol. 2014 Apr;44(4):1213-24. doi: 10.1002/eji.201343794. Epub 2014 Jan 16. PubMed
CSF-1-induced Src signaling can instruct monocytic lineage choice. Endele M, Loeffler D, Kokkaliaris KD, Hilsenbeck O, Skylaki S, Hoppe PS, Schambach A, Stanley ER, Schroeder T. Blood. 2017 Mar 23;129(12):1691-1701. doi: 10.1182/blood-2016-05-714329. Epub 2017 Feb 3. PubMed
Genetic and Mechanical Regulation of Intestinal Smooth Muscle Development. Huycke TR, Miller BM, Gill HK, Nerurkar NL, Sprinzak D, Mahadevan L, Tabin CJ. Cell. 2019 Sep 19;179(1):90-105.e21. doi: 10.1016/j.cell.2019.08.041. PubMed
Transcriptome Profiling Identifies TIGIT as a Marker of T-Cell Exhaustion in Liver Cancer. Ostroumov D, Duong S, Wingerath J, Woller N, Manns MP, Timrott K, Kleine M, Ramackers W, Roessler S, Nahnsen S, Immunoglobulin And Immunoreceptor tyrosiCzemmel, Dittrich-Breiholz O, Eggert T, Kuhnel F, Wirth TC. Hepatology. 2021 Apr;73(4):1399-1418. doi: 10.1002/hep.31466. PubMed
GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells. Booth L, West C, Von Hoff D, Kirkwood JM, Dent P. Front Oncol. 2021 Apr 8;11:656453. doi: 10.3389/fonc.2021.656453. eCollection 2021. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.